Previous studies uncovered that miR-106b could post-transcriptionally inhibit PTEN expression in different cancer cells, such as pituitary adenoma, breast cancer, and colorectal cancer [23,26–28], but whether PTEN was a direct target of miR-106b in human EEC cells remains to be further elucidated. The gene discussed is PTEN; the disease is breast carcinoma.